BIOAGE LABS, INC. Shares Outstanding
BIOAGE LABS, INC. (BIOA) had Shares Outstanding of 45.78 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-05
- 2026-06-30: Shares outstanding (split-adjusted) 45.78M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 44.39M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 37.39M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 35.85M shares; Shares authorized (split-adjusted) 500.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 45.78M shares 10-Q · filed 2026-08-05 | 500.00M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 44.39M shares 10-Q · filed 2026-05-08 | 500.00M shares 10-Q · filed 2026-05-08 |
| 2025-12-31 | 37.39M shares 10-Q · filed 2026-08-05 | 500.00M shares 10-Q · filed 2026-08-05 |
| 2025-09-30 | 35.85M shares 10-Q · filed 2025-11-06 | 500.00M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 35.85M shares 10-Q · filed 2025-08-06 | 500.00M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 35.85M shares 10-Q · filed 2025-05-06 | 500.00M shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 35.85M shares 10-K · filed 2026-03-24 | 500.00M shares 10-K · filed 2026-03-24 |
| 2024-09-30 | 34.20M shares 10-Q · filed 2024-11-07 | 500.00M shares 10-Q · filed 2024-11-07 |
| 2023-12-31 | 1.67M shares 10-K · filed 2025-03-20 | 52.40M shares 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |